Skip to content
HowShorted

MEDICAL PROPERTIES TRUST INC short interest in 2021

In 2021, MEDICAL PROPERTIES TRUST INC's disclosed short interest ran from 2.02% of shares outstanding on 15 Jan 2021 to 5.09% on 31 Dec 2021, a change of +3.07 percentage points. The year's high was 5.09% on 31 Dec 2021 and its low 2.02% on 15 Jan 2021, averaging 3.42% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 10.38 days on 30 Nov 2021. Full history: MEDICAL PROPERTIES TRUST INC.

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for MEDICAL PROPERTIES TRUST INC in 2021

2021 in figures

Start of year
2.02% (15 Jan 2021)
End of year
5.09% (31 Dec 2021)
Change
+3.07 pp
High
5.09% (31 Dec 2021)
Low
2.02% (15 Jan 2021)
Average
3.42%
Highest days to cover
10.38 (30 Nov 2021)
SEC filings marked
8

Every report in 2021

MEDICAL PROPERTIES TRUST INC short interest in 2021
SettlementShort interestDays to coverFilings since previous
15 Jan 20212.02%1.33
29 Jan 20212.13%3.91
12 Feb 20212.71%5.68results (8-K)
26 Feb 20212.72%6.31
15 Mar 20212.15%3.3810-K filed
31 Mar 20212.25%3.70
15 Apr 20212.18%3.68
30 Apr 20212.24%5.08results (8-K)
14 May 20212.03%3.6910-Q filed
28 May 20212.47%4.50
15 Jun 20212.90%3.10
30 Jun 20213.22%3.10
15 Jul 20213.62%4.12
30 Jul 20213.74%6.62results (8-K)
13 Aug 20213.70%6.6910-Q filed
31 Aug 20214.13%8.11
15 Sep 20214.63%3.55
30 Sep 20214.52%5.65
15 Oct 20214.49%7.03
29 Oct 20214.64%7.63results (8-K)
15 Nov 20214.70%10.3410-Q filed
30 Nov 20214.88%10.38
15 Dec 20215.01%7.15
31 Dec 20215.09%6.66

See also: MEDICAL PROPERTIES TRUST INC's full history · most shorted US stocks of 2021 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.